Literature DB >> 14585851

In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa.

Shigeharu Oie1, Toshinari Uematsu, Akihiro Sawa, Hidekazu Mizuno, Masaaki Tomita, Shiro Ishida, Yoshiro Okano, Akira Kamiya.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the combined effects of antibiotic combinations by agar incorporation inhibitory tests and by time-kill tests on seven geographically and epidemiologically distinct isolates of multidrug-resistant Pseudomonas aeruginosa. All seven strains were resistant to piperacillin, meropenem, ceftazidime, cefoperazone-sulbactam, aztreonam, amikacin and ciprofloxacin.
METHODS: Strains were distinguished by pulsed-field gel electrophoresis after DNA extraction and restriction with SpeI. MICs of the seven antibiotics listed above were determined by agar dilution. The effect of combinations of these agents was determined by agar incorporation tests and by time-kill studies.
RESULTS: Among the two-drug combinations, the combination aztreonam and amikacin was the most effective, inhibiting proliferation in five of the seven strains. Among the three-drug combinations, the combinations of piperacillin, ceftazidime and amikacin, and that of ceftazidime, aztreonam and amikacin were the most effective, inhibiting proliferation in all seven strains. In the killing tests, the three-drug combination of ceftazidime, aztreonam and amikacin was the most effective. This three-drug combination had bacteriostatic effects on all seven strains 2, 4, 6 and 24 h after drug addition, synergic effects on 2-3 strains and bactericidal effects on 1-2 strains after 4, 6 and 24 h.
CONCLUSIONS: The three-drug combination of ceftazidime, aztreonam and amikacin may be effective against P. aeruginosa resistant to all commonly used antipseudomonal drugs, and deserves further study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14585851     DOI: 10.1093/jac/dkg478

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Ceftolozane/tazobactam for febrile UTI due to multidrug-resistant Pseudomonas aeruginosa in a patient with neurogenic bladder.

Authors:  Aurélien Dinh; Benjamin Davido; Ruxandra Calin; Julie Paquereau; Clara Duran; Frédérique Bouchand; Véronique Phé; Emmanuel Chartier-Kastler; Martin Rottman; Jérôme Salomon; Patrick Plésiat; Anaïs Potron
Journal:  Spinal Cord Ser Cases       Date:  2017-05-11

2.  In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa.

Authors:  Shigeharu Oie; Yumi Fukui; Masaya Yamamoto; Yuki Masuda; Akira Kamiya
Journal:  BMC Infect Dis       Date:  2009-08-10       Impact factor: 3.090

3.  Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.

Authors:  M Montero; J P Horcajada; L Sorlí; F Alvarez-Lerma; S Grau; M Riu; M Sala; H Knobel
Journal:  Infection       Date:  2009-06-04       Impact factor: 3.553

4.  New options of antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa.

Authors:  I Nakamura; T Yamaguchi; A Tsukimori; A Sato; S Fukushima; T Matsumoto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-29       Impact factor: 3.267

Review 5.  Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?

Authors:  Song Oh; Raymond Chau; Anh T Nguyen; Justin R Lenhard
Journal:  Antibiotics (Basel)       Date:  2021-05-28

6.  Successful Treatment of Multi-Drug Resistant Pseudomonas aeruginosa Bacteremia with the Recommended Renally Adjusted Ceftolozane/Tazobactam Regimen.

Authors:  Ursula C Patel; David P Nicolau; Rabeeya K Sabzwari
Journal:  Infect Dis Ther       Date:  2016-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.